UPDATE: Dyax Corp. (DYAX) Slammed; to Discontinue Ecallantide Phase 2 Based on Results of Interim Analysis

Go back to UPDATE: Dyax Corp. (DYAX) Slammed; to Discontinue Ecallantide Phase 2 Based on Results of Interim Analysis